Revival, Suppression and the Three-Year Clock
Rakesh Mehta, 41, bought a ₹50 lakh, 25-year term plan in March 2019 and paid three annual premiums before the policy lapsed in April 2022. He applied for revival in November 2023, paying ₹1.42 lakh in arrears and interest. The revival health declaration asked whether he had been 'hospitalised or treated for any ailment in the last five years'; he ticked 'No' and signed. Unknown to the insurer, he had been admitted in August 2022 with dilated cardiomyopathy and advised lifelong medication; the discharge summary was in his own file. The revival was approved and the policy became fully in force. He died of cardiac arrest in May 2024, six months after revival. The nominee claims ₹50 lakh. The insurer's underwriter states that, on the August 2022 records, the revival would have been declined outright. The agent argues that the policy had already run for more than three years and that Section 45 of the Insurance Act, 1938 bars the insurer from questioning it now.
1. Does the three-year bar in Section 45 of the Insurance Act, 1938 run from the original commencement date or from the revival date? Set out the reasoning the claims committee should record.
Read the worked answer
Conclusion: the clock runs from the later of issuance and revival, so the insurer is still inside the three-year window.
Reasoning to record:
- Revival is not a clerical condonation of a lapsed policy. The insurer restores the risk only on the strength of a fresh declaration of health, and that declaration becomes the basis on which the revived contract exists. If the revival declaration could never be questioned once the original policy crossed three years, every lapsed policy could be revived with impunity by suppressing whatever happened during the lapse - and the gap year is precisely when the risk most often deteriorates.
- Section 45, as amended in 2015, measures the three-year period from the date of issuance of the policy or the date of revival, whichever is later. Here the revival is dated November 2023 and the death is May 2024, so the policy is well within three years of revival and can be called in question.
- Being inside the window does not entitle the insurer to repudiate. Section 45 sets a procedural bar after three years; before that, the insurer must still prove the ordinary grounds - a material statement that was false, that the insured knew to be false or made recklessly, and that induced the revival. The underwriter's statement that he would have declined is evidence of materiality, not proof of misrepresentation. The committee should record the question asked, the answer given, the medical records that contradict it, and the underwriting note.
- The original three-year period is not a safe harbour for the nominee and the revival date is not a trap for the insurer: either way the file is decided, the decision must rest on the revival declaration, not on the original proposal.
2. What must the insurer establish to succeed, and how should the repudiation letter be framed? Identify the two weakest points in the insurer's file.
Read the worked answer
Elements to establish:
- The question asked was capable of eliciting the information - 'hospitalised or treated for any ailment in the last five years' plainly covers the August 2022 admission.
- The answer was false.
- The condition was material to the decision to revive - supported by the underwriter's note and, ideally, the chief underwriter's opinion that cardiomyopathy on lifelong medication would have led to decline or postponement.
- The false answer induced the revival, i.e. no medical examination or other information put the insurer on notice.
Framing: the letter must plead the specific question, the specific answer, the specific contradicting record and the materiality, and avoid the loose phrase 'non-disclosure of pre-existing disease'. It should state that the revival is being avoided, that the contract is treated as never having been restored, and that the arrears paid are being refunded; it should not read as a forfeiture of premium.
Two weakest points:
- The insurer processed revival without medicals in a few days, which the claimant will say amounts to waiver or at least notice. The answer is that waiver requires knowledge, and the insurer had none - but the processing note must be produced.
- The revival papers may have been completed by an agent or the branch. If the agent was told about the August admission, knowledge of the agent in the same transaction may be imputed to the insurer. That must be investigated before the letter issues, not after.
3. The nominee's adviser proposes to go to the Insurance Ombudsman. Explain the forum, the limits, and what you would advise each side.
Read the worked answer
Forum and limits. The Insurance Ombudsman has jurisdiction over a life policy held by an individual. A complaint lies only after the insurer has rejected the claim or failed to settle it within the period allowed for grievance resolution, and must ordinarily be filed within one year of the rejection. The Ombudsman cannot award more than the monetary limit in the rules - currently ₹30 lakh - so on a ₹50 lakh claim even a wholly favourable award would leave a residue recoverable only by suit. Verify the current limit and limitation rule before advising.
For the nominee: the complaint is free, quick and does not bar a civil suit, but it exposes the file to an independent reading. If the repudiation letter is well pleaded around the revival declaration, the likely outcome is rejection, and time spent may run the limitation clock. A settlement should be explored only on a realistic discount, and only if the insurer is willing to treat the matter as a commercial rather than a precedent file.
For the insurer: treat the complaint as a test of the file. Produce the revival form, the underwriting note, the medical records and the materiality evidence. If any of these is thin - especially if the agent knew of the hospitalisation - the prudent course is to review the repudiation before the Ombudsman does, because an adverse award is published and persuasive in later litigation.